TrialBMC neurology2022
Memantine for the patients with mild cognitive impairment in Parkinson's disease: a pharmacological fMRI study.
Shoji Kawashima et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it